Health Condition 1: K929- Disease of digestive system, unspecified Health Condition 2: K319- Disease of stomach and duodenum, unspecified Health Condition 3: N289- Disorder of kidney and ureter, unspecified Health Condition 4: K87- Disorders of gallbladder, biliarytract and pancreas in diseases classified elsewhere Health Condition 5: C509- Malignant neoplasm of breast of unspecified site Health Condition 6: C73- Malignant neoplasm of thyroid gland Health Condition 7: C029- Malignant neoplasm of
Conditions
Interventions
Intervention1: inj rocuronium: inj rocuronium given intravenous in the dose og 0.6mg per kg at the time of intubation
Control Intervention1: Inj. Vecuronium: inj vecuronium given intravenous in the do
Sponsors
Sir T Hospital
Eligibility
Inclusion criteria
Inclusion criteria: Patients who are willing to give consent to participate in the study. Patients scheduled for elective surgery under general anaesthesia Patients of age between 20 to 60 years of either gender Patients with ASA grade I and II. Patients with BMI of 18 to 25 .
Exclusion criteria
Exclusion criteria: Patient having history of drug allergy to study drug. Patient with renal and hepatic dysfunction. Patient with neuromuscular disorder or medication known to influence neuromuscular functions. Patients with anticipated difficult intubation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessed using stsndardized intubation scoring system based on jaw relaxation, vocal cord posotion and patient response (excellent/good/poor) Timepoint: 60 sec after administration of study drug | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare hemodynamic parameters (MAP , Heart rate and Oxygen saturation )in both groups. To compare side effects and complications if any in both the groupsTimepoint: Before intubation, after intubation 5, 15, 30, 45, 60, 75 and 90min | — |
Countries
India
Contacts
Public ContactDr Poonam verma
GMC Bhavnagar
Outcome results
None listed